New drug cocktail tested for Tough-to-Treat lymphoma
Disease control
Recruiting now
This study aims to find a safe and effective dose for a new combination of cancer drugs. It is for adults whose B-cell non-Hodgkin lymphoma has come back or has not responded to at least two prior treatments. Researchers will test an approved drug, loncastuximab tesirine, alongsi…
Phase: PHASE1 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC